Skip to main content
Eric Winer, MD, Oncology, New Haven, CT

Eric P. Winer MD


Director, Yale Cancer Center Physician-in-Chief, Smilow Cancer Hospital

Join to View Full Profile
  • 35 Park StreetNew Haven, CT 06510

  • Phone+1 617-632-6876

  • Fax+1 617-632-1930

Dr. Winer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1987 - 1989
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterInternship, Internal Medicine, 1983 - 1984
  • Yale School of Medicine
    Yale School of MedicineClass of 1983

Certifications & Licensure

  • ME State Medical License
    ME State Medical License Current
  • CT State Medical License
    CT State Medical License 2021 - 2025
  • MA State Medical License
    MA State Medical License 1997 - 2023
  • NC State Medical License
    NC State Medical License 1987 - 1999
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Boston Magazine Castle Connolly, 2008-2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer  
    Eric P Winer, Louise C Walter, Mina S Sedrak, Tanya M Wildes, Stuart M Lichtman, Kathryn J Ruddy, JAMA Oncology
  • Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer  
    Sara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology
  • Pembrolizumab Monotherapy for Previously Untreated, PD-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B of the Phase II KEYNOTE-086 Study  
    M C Liu, R Nanda, H S Rugo, E P Winer, S Adams, Annals of Oncology
  • Join now to see all

Lectures

  • Breast Cancer, New Horizons, Current Controversies 
    Harvard Medical School, Boston, Massachusetts - 7/11/2013
  • 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium(SABCS) 
    UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
  • Breast Cancer, New Horizons, Current Controversies 
    Harvard Medical School, Boston, Massachusetts - 7/12/2012

Press Mentions

  • This 25-Year-Old Survived Breast Cancer. Now, She's Dealing with Menopause
    This 25-Year-Old Survived Breast Cancer. Now, She's Dealing with MenopauseJuly 31st, 2025
  • Researchers Aim to Adapt Metastatic Breast Cancer Therapy as Tumors Change
    Researchers Aim to Adapt Metastatic Breast Cancer Therapy as Tumors ChangeJuly 2nd, 2025
  • Improved Breast Cancer Outcomes with Less Invasive Surgery
    Improved Breast Cancer Outcomes with Less Invasive SurgeryMay 5th, 2025
  • Join now to see all

Grant Support

  • Immune Dysfunction in HIV associated Lung Cancer (Immuno/Microenvironment)YALE UNIVERSITY1997–2029
  • Immune Dysfunction in HIV associated Lung Cancer (Immuno/Microenvironment)YALE UNIVERSITY1997–2029
  • Cancer Center Support GrantYALE UNIVERSITY1997–2029
  • Immune Dysfunction in HIV associated Lung Cancer (Immuno/Microenvironment)YALE UNIVERSITY1997–2029
  • Integrated Infectious Diseases and Cancer Care to Address SDOH for Patients with HIV-associated Cancer (Social Determinants of Health and Quality of Cancer Care in HIV-associated Cancers)YALE UNIVERSITY1997–2025
  • Clinical Studies CoreNational Cancer Institute2008–2009
  • Cancer And Leukemia Group BNational Cancer Institute2006–2008
  • C-2: Clinical Study CoreNational Cancer Institute2005–2007
  • Psychosocial Outcomes/Health Behaviors: Women With DCISNational Cancer Institute2000–2002
  • Tailored Information Materials About BRCA1 TestingNational Cancer Institute1995–1996

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: